FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

FDA Halts Some Cell Clinical Trials

FDA says it is reviewing all clinical trials that rely on a Biden administration exemption that allowed sensitive biological material, including DNA, ...

latest-news-card-1
Biologics

Top 2 FDA Cell/Gene Therapies Officials Pushed Out

FDA places CBER Office of Therapeutic Products director Nicole Verdun and her deputy Rachael Anatol on administrative leave in the latest shake-up at ...

latest-news-card-1
FDA General

Securing Technology, Equipment Report

The FDA Office of Regulatory and Emerging Science publishes a report describing agency efforts to research cybersecurity and advanced manufacturing is...

Human Drugs

Bavarian Nordic Sells Priority Voucher for $160 Million

Bavarian Nordic enters into an agreement to sell for $160 million a priority review voucher that was awarded for gaining approval of its chikungunya v...

latest-news-card-1
Human Drugs

Court OKs FDA Ozempic Drug Shortage Action

A Texas federal judge rules FDA acted properly in removing Novo Nordisks Ozempic and Wegovy from its drug shortage list.

Biologics

Gottlieb Believes CBER Will Probe Sarepta Approval

Former FDA commissioner Scott Gottlieb expects FDA will reevaluate Sareptas approval of Duchenne muscular dystrophy gene therapy Elevidys based on two...

latest-news-card-1
FDA General

FDA Webview Closed on Juneteenth (6/19)

FDA Webview closes and will not be publishing on 6/19 in recognition of the U.S. federal holiday, Juneteenth.

latest-news-card-1
Human Drugs

FDA Warns on Transderm Scop Heat Complications

FDA warns that Baxter Healthcares antinausea patch Transderm Scop (scopolamine transdermal system) can increase body temperature and cause heat-relate...

latest-news-card-1
Marketing

DTC Ads Kennedys Next Target?

Bloomberg News says President Trump and HHS secretary Kennedy are looking at policies that they hope would drive drug companies away from DTC advertis...

latest-news-card-1
Human Drugs

FDA Approves Gileads Yeztugo for HIV Prevention

FDA approves Gileads Yeztugo as the only HIV pre-exposure prophylaxis twice-yearly option.